Given that HOXA9, the most important downstream gene in MLL leukemia, was reported to have enhancer-binding preference [44] and to rewire leukemia-specific enhancers [25], we speculated that HOXA genes might mediate the programming of the SEELA enhancer. Here, HOXA9 is linked to leukemia.